Submit Content
Get the latest delivered to your inbox
Privacy Policy

Merck & Co., Inc.

Today’s Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions.

We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

    Merck Institute for Science Education Launches Three-Year Program to Improve Science Teaching in New Jersey and Pennsylvania Public Schools Image

    POSTED 

    08-04-08

    Merck Institute for Science Education Launches Three-Year Program to Improve Science Teaching in New Jersey and Pennsylvania Public Schools

    WHITEHOUSE, N.J. - August 4, 2008 - The Merck Institute for Science Education (MISE) announced today that it has launched The Academy for Leadership in Science Instruction, a new three-year program to improve science instructional practice within public schools in New Jersey...

    National Society of Black Engineers Honors UNCF/Merck Science Initiative With Golden Torch Award Image

    POSTED 

    05-20-08

    National Society of Black Engineers Honors UNCF/Merck Science Initiative With Golden Torch Award

    WHITEHOUSE STATION, NJ - MAY 20, 2008 - The UNCF/Merck Science Initiative was recently honored by the National Society of Black Engineers (NSBE) with the 2008 Golden Torch Award for Corporate/Education Partnership at the NSBE Annual National Convention in Orlando, Florida. ...

    Merck Sets Target to Reduce Global Greenhouse Gas Emissions by 12 Percent Image

    POSTED 

    02-20-08

    Merck Sets Target to Reduce Global Greenhouse Gas Emissions by 12 Percent

    WHITEHOUSE STATION, NJ - February 20, 2008 - Merck & Co., Inc. today announced plans to reduce greenhouse gas emissions from the Company's global operations by 12 percent by the end of 2012, using 2004 as its base year. The announcement was made as part of Merck's part...

    Merck Company Foundation Expands Network of Immunization Training Centers in Africa Image

    POSTED 

    11-19-07

    Merck Company Foundation Expands Network of Immunization Training Centers in Africa

    WHITEHOUSE STATION, N.J. - November 19, 2007 - The Merck Company Foundation announced today a $2.8 million commitment to establish two new immunization training centers in Uganda and Zambia and to expand the Foundation's support of two existing centers in Kenya and Mali as p...

    Public Health Officials Announce First Country to Eliminate Transmission of the Tropical Disease Onchocerciasis Image

    POSTED 

    11-15-07

    Public Health Officials Announce First Country to Eliminate Transmission of the Tropical Disease Onchocerciasis

    WHITEHOUSE STATION, NJ, USA, and QUITO, ECUADOR - November 15, 2007 - Public health officials gathering at the 17th Inter-American Conference on Onchocerciasis (IACO) in Quito, Ecuador, today announced that transmission of the tropical disease onchocerciasis (also known as r...

    Recipients of The Merck Index Women in Chemistry Scholarship Announced Image

    POSTED 

    08-20-07

    Recipients of The Merck Index Women in Chemistry Scholarship Announced

    WHITEHOUSE STATION, N.J. - Aug. 20, 2007 - Merck & Co. Inc., today announced the winners of the first annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in medicinal or synth...

    New Step-by-Step Guidelines Now Available for Developing an HIV/AIDS Prevention and Treatment Program in the African Workplace Image

    POSTED 

    05-31-07

    New Step-by-Step Guidelines Now Available for Developing an HIV/AIDS Prevention and Treatment Program in the African Workplace

    WASHINGTON, DC- May 31, 2007 "“ During the 34th Annual Global Health Conference Meeting here today Merck & Co., Inc.*, announced the release of the "Blueprint for Business Action on HIV/AIDS." The Blueprint is an innovative tool developed by a predominately...

    Merck & Co., Inc. Grants License for HIV/AIDS Drug Efavirenz to South African Company, Thembalami Pharmaceuticals, in Effort to Accelerate Access to Life-Saving Treatment Image

    POSTED 

    07-13-04

    Merck & Co., Inc. Grants License for HIV/AIDS Drug Efavirenz to South African Company, Thembalami Pharmaceuticals, in Effort to Accelerate Access to Life-Saving Treatment

    WHITEHOUSE STATION, N.J., U.S.A. - Merck & Co., Inc., (the parent company of MSD (Pty) Ltd. South Africa) announced today that it has signed an agreement to grant a non-exclusive patent license for the manufacture and sale of a generic version of efavirenz to Them...

    The Bill & Melinda Gates Foundation, Merck & Co., Inc., and The Republic of Botswana Launch New HIV Initiative Image

    POSTED 

    07-10-00

    The Bill & Melinda Gates Foundation, Merck & Co., Inc., and The Republic of Botswana Launch New HIV Initiative

    The Bill & Melinda Gates Foundation, Merck & Co., Inc. and the Republic of Botswana today announced the establishment of the Botswana Comprehensive HIV/AIDS Partnership, a new initiative to improve the overall state of HIV/AIDS care and treatment in Botswana. In coll...

    Merck & Co., Inc. Logo

    Merck & Co., Inc.

    Merck & Co., Inc.

    Join today and get the latest delivered to your inbox